Generali Asset Management SPA SGR Purchases Shares of 9,850 The Cooper Companies, Inc. (NASDAQ:COO)

Generali Asset Management SPA SGR acquired a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 9,850 shares of the medical device company's stock, valued at approximately $906,000.

A number of other hedge funds have also recently bought and sold shares of COO. Raymond James Financial Inc. acquired a new stake in shares of Cooper Companies during the 4th quarter worth approximately $64,826,000. Victory Capital Management Inc. grew its holdings in Cooper Companies by 14.6% during the 4th quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company's stock worth $415,985,000 after acquiring an additional 574,899 shares during the period. JPMorgan Chase & Co. raised its position in shares of Cooper Companies by 13.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company's stock valued at $543,979,000 after acquiring an additional 573,908 shares during the last quarter. Wealthfront Advisers LLC boosted its position in shares of Cooper Companies by 4,594.1% in the 4th quarter. Wealthfront Advisers LLC now owns 569,812 shares of the medical device company's stock worth $52,383,000 after purchasing an additional 557,673 shares during the last quarter. Finally, Alecta Tjanstepension Omsesidigt acquired a new stake in shares of Cooper Companies during the fourth quarter worth $49,550,000. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Stock Down 0.4 %

NASDAQ COO traded down $0.37 on Tuesday, reaching $83.70. The company had a trading volume of 1,669,122 shares, compared to its average volume of 1,287,437. The company's fifty day moving average is $89.90 and its 200-day moving average is $97.88. The firm has a market capitalization of $16.74 billion, a price-to-earnings ratio of 42.92, a price-to-earnings-growth ratio of 2.25 and a beta of 1.02. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The Cooper Companies, Inc. has a 1-year low of $77.05 and a 1-year high of $112.38.

Remove Ads

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, hitting the consensus estimate of $0.92. The company had revenue of $964.70 million during the quarter, compared to analysts' expectations of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. On average, research analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have weighed in on COO shares. BNP Paribas raised Cooper Companies to a "hold" rating in a research note on Thursday, March 13th. Piper Sandler reissued an "overweight" rating and set a $115.00 price objective (down previously from $120.00) on shares of Cooper Companies in a research note on Friday, March 7th. Citigroup lowered their target price on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating for the company in a research note on Friday, March 7th. StockNews.com cut shares of Cooper Companies from a "buy" rating to a "hold" rating in a research report on Wednesday, December 11th. Finally, Robert W. Baird lowered their price objective on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a research report on Friday, March 7th. Four investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $110.25.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.